Migraine Medications

Name: Migraine Medications
Uploaded: 2021-08-03T14:00:23.000Z
Duration: 1 h 22 min 14 s

Understanding the Pharmacology of Migraine Medications

Introduction to Migraine Medications

The video introduces the topic of migraine medications, emphasizing the importance of viewer engagement through likes and subscriptions.

Pathophysiology of Migraines

A brief overview is provided on the pathophysiology of migraines, highlighting irritation and activation of trigeminal nerves within the meninges.

Key neurotransmitters involved in migraine development include vasoactive peptide, substance P, and calcitonin gene-related peptide (CGRP).

Mechanisms Leading to Migraine Symptoms

Release of histamines from mast cells causes vasodilation and increased capillary permeability, contributing to inflammation during a migraine.

Prostaglandins also play a role in similar inflammatory responses leading to migraine symptoms.

Activation of Trigeminal Nerve

Inflammatory mediators activate cranial nerve five (trigeminal nerve), sending pain signals to the brain's thalamus and sensory cortex.

The trigeminal nerve is responsible for sensation in facial regions; its activation leads to classic headache presentations associated with migraines.

Auras Associated with Migraines

Auras may precede migraines, theorized to be linked with serotonin levels affecting blood vessel constriction or dilation.

Higher serotonin levels are associated with aura experiences while lower levels correlate with headache phases.

Treatment Approaches: Acute vs. Prophylactic Therapy

Acute Therapy for Migraines

Initial treatment focuses on reducing inflammation using NSAIDs like ibuprofen or naproxen; ketorolac may be used if oral intake isn't possible.

First-line acute treatments include triptan drugs that increase serotonin concentration; ergots serve as second-line options.

Prophylactic Therapy for Chronic Migraines

Beta-blockers such as propranolol and metoprolol are first-line prophylactic agents aimed at preventing future migraines by inducing vasoconstriction.

Anti-convulsants like topiramate and valproate are utilized despite unclear mechanisms but may reduce neurogenic inflammation.

Mechanism of Action for Specific Drugs

Tryptans: First-Line Agents

Tryptans (e.g., sumatriptan, zolmitriptan), can be administered orally or via injection; they target specific serotonin receptors (5HT1B/D).

Effects on Neurogenic Inflammation

By inhibiting release of vasoactive peptides, tryptans decrease neurogenic inflammation which reduces pain signaling through cranial nerve five.

Ergots: Second-Line Agents

Ergots like dihydroergotamine act similarly but bind more broadly across various 5HT receptors; they can induce peripheral vasoconstriction via alpha-one receptor interaction.

Additional Therapeutic Options

Anti-inflammatory Treatments

NSAIDs inhibit prostaglandin release while steroids like dexamethasone help reduce overall inflammatory reactions during acute attacks.

Prophylactic Strategies Continued

Tricyclic Antidepressants

Amitriptyline may enhance serotonin levels leading to reduced vasodilation effects associated with migraines.

CGRP Antagonists

These drugs directly inhibit CGRP activity, reducing neurogenic inflammation and pain signaling pathways effectively.

Botulinum Toxin

Type A botulinum toxin decreases pain signal transmission along trigeminal nerves by inhibiting synaptic vesicle release at targeted injection sites.

Overview of Migraine Medications and Their Adverse Effects

Introduction to Medication Classes

The main classes of migraine medications discussed include triptans, ergots (like dihydroergotamine), and CGRP antagonists. Other medications will be addressed in future discussions.

Adverse Effects of Triptans

Triptans cause vasoconstriction not only in cerebral vessels but also in coronary and systemic blood vessels, which can lead to serious cardiovascular issues such as angina or myocardial infarction.

Patients with a history of coronary artery disease or severe hypertension should avoid triptans due to the risk of exacerbating these conditions. Potential adverse effects include increased blood pressure and peripheral artery disease.

Triptans may induce paresthesias or cold extremities due to altered nerve sensations from vasoconstriction. This is an important consideration for patient management.

These medications are contraindicated during pregnancy because they can induce smooth muscle contractions, posing risks to fetal health.

Key Considerations for Tryptan Use

Important contraindications for triptan use include unstable angina, peripheral artery disease, and high blood pressure due to their vasoconstrictive properties affecting both central and peripheral circulation.

Ergots: Second-Line Treatment

Ergots share similar adverse effects with triptans, including vasoconstriction that can worsen coronary artery disease symptoms like angina or lead to myocardial infarction in susceptible patients.

They stimulate serotonin receptors in the chemoreceptor trigger zone, potentially causing nausea and vomiting as side effects when used frequently.

Ergots are also contraindicated during pregnancy due to their ability to induce uterine contractions, which could harm fetal development.

Liver Function Concerns with Ergots

Prolonged use of ergots can elevate liver function tests (LFTs), indicating hepatotoxicity; monitoring LFT levels is essential for patients on these medications regularly.

Serotonin Syndrome Risk Factors

Co-administration of triptans with other serotonergic agents (e.g., SSRIs or tricyclic antidepressants) increases the risk of serotonin syndrome characterized by agitation, delirium, tachycardia, hypertension, hyperthermia, diaphoresis, and gastrointestinal disturbances like diarrhea.

Symptoms Associated with Serotonin Syndrome

Increased activity from muscle spindles leads to hypertonia and hyperreflexia; this condition requires prompt diagnosis and treatment due to its potential severity if left unaddressed.

Ergot Toxicity Overview

Ergot toxicity presents through convulsive seizures and gangrenous necrosis resulting from severe vasoconstriction; treatment typically involves anticoagulants and vasodilators alongside supportive care measures for affected patients.

CGRP Antagonists: A Safer Option?

CGRP antagonists have minimal side effects primarily limited to injection site pain; however, they carry a risk for anaphylactic reactions given their monoclonal antibody nature requiring careful monitoring during administration.

This structured overview provides a comprehensive understanding of migraine medication pharmacology while highlighting critical safety considerations associated with each class discussed.